Decentralized Growth Curavit specializes in fixing the execution layer of clinical trials, enabling sponsors to recruit, enroll, and manage participants at national scale using a remote site network. The launch of HEOR services for digital therapeutics signals a growing need for outcomes research in decentralized models. This positions Curavit to upsell to sponsors pursuing faster, more predictable enrollment and higher-quality data in digital therapy programs, while collaborating with existing CROs to extend reach.

HEOR Opportunity Recent HEOR practice expansion highlights a strategic bet on outcomes research as a core service for pharma and digital therapeutics. Sponsors increasingly require HEOR data for regulatory submissions and market access, creating cross-sell opportunities for Curavit’s trial execution platform to provide both study operations and health economics insights.

Growth Momentum Strong funding signals and visible expansion efforts indicate credible growth momentum and a pathway to larger pharmaceutical partnerships. This suggests potential to engage mid-market to larger sponsors seeking scalable remote trial capabilities that integrate with other CROs and trial infrastructure.

Secure Data Platform Curavit’s tech stack emphasizes secure, interoperable data management with Google Cloud Healthcare API and JSON-LD, enabling clean integration with sponsor systems and EDC platforms while delivering high-quality, longitudinal data essential for HEOR analyses.

CRO Collaboration Positioning as a CRO and Remote Clinical Site designed to work seamlessly with existing CROs and sites creates a compelling partnership model for large CROs seeking to augment remote site capacity and accelerate decentralized trials.